TGFB1 and non-small cell lung carcinoma: Previous research has shown that fucoidan effectively inhibits the activation of the TGF-β1 signaling pathway in various cell lines, including those of liver cancer, breast cancer, and non-small cell lung cancer, thereby suppressing the metastasis of malignant cells (20).